CStone Pharmaceuticals
CStone Pharmaceuticals (CSPHF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CSPHF · as of Jun 8, 2026
Key Statistics
Explore CStone Pharmaceuticals Data
csphf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
csphf competitorsCSPHF
ASCLF
CHIZF
CSBTF
MEOBF
NURPFStock Performance
Full HistoryAbout CStone Pharmaceuticals
CStone Pharmaceuticals a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and…
what is cstone pharmaceuticals · csphf stock overview · cstone pharmaceuticals company profile · who is cstone pharmaceuticals ceo · csphf OTC · cstone pharmaceuticals headquarters · cstone pharmaceuticals business segments
About Stock Overview & Key Data
CStone Pharmaceuticals (CSPHF) is a Healthcare company in the Biotechnology industry, listed on OTC since Sep 14, 2020. As of the latest trading session, CSPHF stock price is $0.69, with a market capitalization of $1.1B. The stock has returned +34.17% over the past 12 months and -22.17% year-to-date.
In fiscal year 2025, CStone Pharmaceuticals reported revenue of $262.6M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CStone Pharmaceuticals (CSPHF) stock price is $0.69. The stock is traded on OTC under the ticker symbol CSPHF. The 52-week range is $0.52 – $1.01.